Tesamorelin only targets dangerous belly fat in HIV patients, leaving other fat stores like arms and legs unchanged.

Scientific Claim

Tesamorelin does not reduce limb or abdominal subcutaneous fat in HIV-infected patients with central fat accumulation after 6 months of treatment.

Original Statement

“with no change in limb or abdominal SC fat.”

From study:Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The study is a randomized controlled trial with a control group, which allows for causal inference. The verb 'does not reduce' is appropriate for this design.

Evidence from Studies

Supporting (0)

No supporting evidence found

Contradicting (1)

Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Randomized Controlled Trial

Human

2010 Mar

The study found that tesamorelin shrinks belly fat inside the abdomen but doesn’t make the outer fat on the limbs or belly smaller — so the claim that it doesn’t reduce that outer fat is correct.

Source Study

Effects of Tesamorelin, a Growth Hormone–Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension

Score: 81

DOI: 10.1097/QAI.0b013e3181cbdaff

Similar Assertions

The drug doesn’t make you lose fat from your skin or your arms and legs — it only targets the fat deep inside your belly, which is the kind that’s most dangerous.

94%

A hormone treatment called tesamorelin doesn't change the fat under the skin in people with HIV who have excess belly fat after six months of treatment.

93%

Continuing tesamorelin for a full year helps HIV patients with belly fat lose nearly 18% of their dangerous internal belly fat, with no loss of benefit over time.

93%

If HIV patients stop taking the injection, the belly fat they lost comes right back quickly.

91%

The drug shrinks the fat around the torso and makes the waist smaller, but doesn’t change the fat on the arms, legs, or just under the skin — meaning it targets only the dangerous internal fat.

91%